Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06698627 · ClinicalTrials.gov registry record · NA
Comparison of Two Over the Counter Intravaginal Devices for the Treatment of Stress Urinary Incontinence
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06698627: Completed NA study, sponsored by Vanderbilt University Medical Center.
NCT06698627 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06698627, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this pilot study is to compare two commercially available over the counter devices for treatment of stress urinary incontinence in a web based format. The main questions it aims to answer 1. What device do women with SUI prefer after using both devices 2. What patient factors help drive this preference if any 3. Is a web-based crossover intervention study feasible Participants will: Use two over the counter devices over a course of 20 days. They will have both devices sent via mail. They will answer questions prior to the start of using any device and then after using each device They will be asked to complete daily bladder diaries
Primary Outcome
Women will be asked to rate each device on a 5 point Likert scale of 1-5. The options for responses will include very favorable, favorable, neutral, unfavorable, very unfavorable. The response for each device will then be compared.
Interventions
- DEVICE Daily Disposable Continence Device
- DEVICE Monthly Disposable Continence Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What the finished NCT06698627 record still lists
NCT06698627 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Daily Disposable Continence Device is the first listed.
NCT06698627 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06698627 about?
NCT06698627 is a clinical study titled "Comparison of Two Over the Counter Intravaginal Devices for the Treatment of Stress Urinary Incontinence". The goal of this pilot study is to compare two commercially available over the counter devices for treatment of stress urinary incontinence in a web based format. The main questions it aims to answer 1. What device do women with SUI prefer after using both devices 2. What patient factors help driv...
What is the current status of trial NCT06698627?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2025-06-30. Estimated completion is 2026-06-01.
What interventions are being tested in trial NCT06698627?
The interventions under investigation include: Daily Disposable Continence Device (DEVICE), Monthly Disposable Continence Device (DEVICE).
Who is sponsoring clinical trial NCT06698627?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06698627's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI